Re: Judikael R. Saout, Gwendoline Lecuyer, Simon Léonard, et al. Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients. Eur Urol. 2023;83:441-51

Affiliations

¹ Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
² Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany. Electronic address: matthias.schwab@ikp-stuttgart.de.

Comment

Anna Reustle et al. Eur Urol. 2023 Sep.

. 2023 Sep;84(3):e72.

doi: 10.1016/j.eururo.2023.04.036. Epub 2023 May 17.

¹ Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
² Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany. Electronic address: matthias.schwab@ikp-stuttgart.de.

No abstract available

Comment on

Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients.
Saout JR, Lecuyer G, Léonard S, Evrard B, Kammerer-Jacquet SF, Noël L, Khene ZE, Mathieu R, Brunot A, Rolland AD, Bensalah K, Rioux-Leclercq N, Lardenois A, Chalmel F. Saout JR, et al. Eur Urol. 2023 May;83(5):441-451. doi: 10.1016/j.eururo.2023.02.008. Epub 2023 Feb 15. Eur Urol. 2023. PMID: 36801089